Skip to main content

2nd. Circuit Court Refuses To Revive 60 Eliquis Lawsuits

2nd. Circuit Court Refuses To Revive 60 Eliquis Lawsuits

2nd. Circuit Court Refuses To Revive 60 Eliquis Lawsuits

Introduction

On Tuesday, March 26, the 2nd U.S. Circuit Court of Appeals in New York upheld the dismissal of 60 Eliquis lawsuits targeted at Bristol-Myers Squibb and Pfizer Inc., related to the dangers of their blood thinner drug.

According to the federal court of appeals, a lower court was not wrong in refusing to send 45 cases back to Delaware state court and ruling that all of the plaintiffs' state law claims raised in the 60 cases were preempted by federal law. The companies named in the lawsuits are blamed over the drug labels requiring warnings about internal bleeding and correction in dosages to minimize those risks.

Another popular blood thinner drug, Xarelto has been blamed for causing gastrointestinal bleeding, hemorrhagic stroke, deep vein thrombosis (DVT), and other serious complications. Defendants Bayer AG and Janssen Pharmaceuticals recently announced the $775 million settlement which will be resolving more than 25,000 Xarelto lawsuits consolidated in the federal multidistrict litigation (MDL No.2592; In Re: Xarelto (Rivaroxaban) Products Liability Litigation) in the Eastern District of Louisiana.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Purdue, Sacklers Agree to $7.4B Opioid Settlement

Categories: Opioids

Purdue Pharma and its owners, the Sackler family, have agreed to a $7.4 billion settlement to resolve thousands of lawsuits accusing the…

Paraquat Trials Scheduled for October 2025 & April 2026

Categories: Paraquat

A U.S. District Judge overseeing thousands of federal

UGA College of Pharmacy Gets $1M+ to Fight Opioid Crisis

Categories: Opioids

Faculty from the University of Georgia’s College of Pharmacy have been awarded a nearly $1.2 million grant from the Georgia Opioid Crisis…

Get 5 Free Medical Record Reviews – No Risk, No Contracts!      
Only 10 firms will be accepted!

Valid until February 28, 2025.